Arm is a British semi-conductor and software design company. Arm committed £1 million to Gavi in 2021, which was matched by the Gavi Matching Fund. This commenced a new strategic partnership between Gavi, Arm and UK-based non-profit Simprints, to help solve the global identification gap. The partnership aims to develop a unique, contactless, digital identification solution that is accurate, scalable and cost-effective. Guided by Gavi’s expertise in immunisation, the project deploys Simprints’ biometrics solution with support from Arm’s technology, global network and funding.
In 2023, Arm committed a further US$ 1 milllion to Gavi, which was also matched by the Gavi Matching Fund. Through this agreement, Arm will invest £1 million over two years in INFUSE. Of this, Arm has earmarked half the amount to continue support of an expanded project of contactless biometrics for immunisation to be implemented by Simprints. The other half of the funding will be allocated to other INFUSE Pacesetters sourced and recommended by Gavi, and approved by Arm.
Proceeds are funds made available to Gavi from donor contributions and commitments, either through: cash payments made to Gavi, through frontloading via the capital markets of a future donor commitment to IFFIm; or Advance Market Commitment (AMC) funds released to Gavi via the World Bank. IFFIm proceeds are allocated over five-year periods coinciding with Gavi’s strategic periods. Proceeds for the current and future strategic periods are indicative until the end of each period and could be revised following changes in market conditions (interest rates or foreign exchange rates), the signing of new pledge(s) and/or changes in IFFIm’s disbursement profile.
Click on Direct, IFFIm, AMC or Matching Fund in the above key to toggle their data on the graph, click again to show the data
Notes:
Direct Contributions (including Matching Fund)
Received contributions: non-US$ contributions for 2000–2023 and Q1-Q2 2024 are expressed in US$ equivalents using the exchange rates on the dates of receipt. For 2014–2023 and Q1-Q2 2024, where contributions were hedged to mitigate currency risk exposure, these have been expressed using the rates applicable to the hedge agreement.
Future contributions (for pledges made prior to the June 2020 donor pledging conference): non-US$ direct contribution and Gavi Matching Fund pledges for Q3-Q4 2024 and for years 2025 and beyond are expressed in US$ equivalents using the applicable “forecast rates” from Bloomberg as of 30 June 2024 or using the rates applicable to any hedge agreement in place.
Future contributions (for pledges at the June 2020 donor pledging conference): non-US$ direct contribution and Gavi Matching Fund pledges for Q3-Q4 2024 and for years 2025 and beyond are expressed in US$ equivalents using the “spot rates” from Refinitiv as at 30 June 2024 or using the rates applicable to any hedge agreement in place.
IFFIm contributions
Received contributions: non-US$ contributions for 2000–2023 and for Q1-Q2 2024 are expressed in US$ equivalents as confirmed by the World Bank Group’s International Bank for Reconstruction and Development (IBRD).
Future contributions: non-US$ contributions for Q3-Q4 2024 and for years 2025 and beyond are expressed in US$ equivalents as follows:
General notes regarding IFFIm contributions:
Due to IFFIm’s nature as a frontloading vehicle, yearly contributions paid into IFFIm can differ significantly from yearly proceeds transferred to Gavi.
While IFFIm grants are irrevocable and legally binding, they are subject to a Grant Payment Condition that can potentially reduce the donor’s amount due, in the event that a Gavi-supported programme country is in protracted arrears with the International Monetary Fund (IMF). Since 29 June 2021, no reduction applies, as all countries from the reference portfolio have cleared their arrears with the IMF.